Topical corticosteroids
This article was originally published in The Tan Sheet
Executive Summary
FDA's Generic Drugs and Dermatologic Drugs Advisory Committees will meet jointly "sometime this fall" to help FDA finalize its interim guidance on bioequivalence standards for topical corticosteroids, FDA Office of Generic Drugs Acting Director Douglas Sporn told a recent National Association of Pharmaceutical Manufacturers meeting. The committees last discussed topical corticosteroids in March 1992, and an interim guidance was issued in July 1992
FDA's Generic Drugs and Dermatologic Drugs Advisory Committees will meet jointly "sometime this fall" to help FDA finalize its interim guidance on bioequivalence standards for topical corticosteroids, FDA Office of Generic Drugs Acting Director Douglas Sporn told a recent National Association of Pharmaceutical Manufacturers meeting. The committees last discussed topical corticosteroids in March 1992, and an interim guidance was issued in July 1992. |